Trial
NCT01616160
An Open-label Study to Identify Molecular Markers of Steroid Resistance
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
Merck Sharp & Dohme LLC; Massachusetts Eye and Ear Infirmary
Condition
Nasal Polyps
Intervention
mometasone furoate
Why stopped
Inability to recruit additional subjects.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-06-12